Skip to main content

MOHS MICROGRAPHIC SURGERY EVALUATION AND TREATMENT OF MICROCYSTIC ADNEXAL CARCINOMA

Tracking # 20-1065900

$99999.00

There are no ratings for this course

Learn more
CE Broker Reporting Reported automatically
Method Computer-Based Training

Course overview

MICROCYSTIC ADNEXAL CARCINOMA (MAC) IS A RARE CUTANEOUS NEOPLASM OF FOLLICULAR AND SWEAT GLAND DIFFERENTIATION. THE LOCALLY AGGRESSIVE NATURE AND DEEP INFILTRATION MAKE COMPLETE EXCISION OF THE TUMOR WITH MARGIN CONTROL A CRUCIAL PART OF MANAGEMENT. IN CONTRAST, MAC IS REPORTED TO HAVE A RELATIVELY HIGH RECURRENCE RATE WITH STANDARD-WIDE LOCAL EXCISION (60% IN SOME CASE SERIES). MORE FAVORABLE CURE RATES WITH LOWER RECURRENCE RATES ARE REPORTED WITH MOHS MICROGRAPHIC SURGERY (MMS). THIS ACTIVITY REVIEWS THE CLINICAL DIAGNOSIS AND TREATMENT OF MICROCYSTIC ADNEXAL CARCINOMA AND HIGHLIGHTS THE CRITICAL ROLE OF EARLY DIAGNOSIS AND TREATMENT.

Subject areas

This course counts toward the state boards and subject areas below.

Bahamas Medical Council

Specialty Medical Practitioner

1.5h General Medicine

Louisiana State Board of Medical Examiners - Physicians & Surgeons

Physician & Surgeon

1.5h Category I CME

Mississippi State Board of Medical Licensure

Medical Doctor

1.5h AMA Category I

Physician Assistant

1.5h AMA Category I

State Medical Board of Ohio

Doctor of Medicine

1.5h AMA Category I